Skip to content

Effects of Pilates and open-label placebos in primary dysmenorrhea – a pilot randomized controlled trial.

Effects of Pilates and open-label placebos in primary dysmenorrhea – a pilot randomized controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00028467
Enrollment
30
Registered
2022-03-02
Start date
2022-03-03
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N94.4

Interventions

Group 1: Pilates training twice weekly Group 2: Placebo capsules twice daily Group 3: No treatment

Sponsors

Hochschule für angewandte Wissenschaften Coburg
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: Self-reported regular menstrual cycle (approximately 26-34 days), dysmenorrhea during the last 3 periods = 6 on an 11-level NRS, primary dysmenorrhea and/or no known medical cause for the dysmenorrhea, sufficient knowledge of German to answer the questionnaires, written informed consent for study participation and data collection, no practice of Pilates training within the last year, refraining from new physical activities and of taking placebos for the duration of the study, apart from the study interventions.

Exclusion criteria

Exclusion criteria: Use of psychotropic drugs and/or manifest mental illness (e.g., recurrent depression, generalized anxiety disorder, addictive disorder), use of hormonal contraceptives (during the last three periods), pregnancy or lactation, intensive physical training.

Design outcomes

Primary

MeasureTime frame
Group differences (both Pilates and open-label placebos vs. no treatment) of the pre-post change in menstrual pain (composite score of minimum, maximum, and average pain assessed on 11-point numeric rating scales, NRS) on the first 3 days of menstrual cycle.

Secondary

MeasureTime frame
Group differences of pre-post changes in salivary prostaglandin concentration (PGE2, PGF2alpha), depression, anxiety, and stress levels (DASS), physical and psychological quality of life (SF-12). In addition, the role of treatment expectations (TEX-Q, 11-point NRS) as well as differences in outcomes between the Pilates and the open-label placebo groups will be explored.

Countries

Germany

Contacts

Public ContactSandra Ort

Hochschule für angewandte Wissenschaften Coburg

sandra.ort@stud.hs-coburg.de+495613178030

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026